Fda Alerts Article Listing | RxWiki

FDA Alerts

FDA Approves Rx for Diabetic Retinopathy

The U.S. Food and Drug Administration today expanded the approved use for Lucentis (ranibizumab injection) 0.3 mg to treat diabetic retinopathy (DR) in patients with diabetic macular edema (DME).

REFINE

medications
- - Remove Lucentis filter (-) Remove Lucentis filter Lucentis
conditions
- - Remove Diabetes filter (-) Remove Diabetes filter Diabetes
  - Apply Eye Disease filter Eye Disease (1) Apply Eye Disease filter
    Apply Diabetic Retinopathy filter Diabetic Retinopathy (1) Apply Diabetic Retinopathy filter